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Abstract
In order to detect linkage of the simulated complex disease Kofendrerd Personality Disorder
across studies from multiple populations, we performed a genome scan meta-analysis (GSMA).
Using the 7-cM microsatellite map, nonparametric multipoint linkage analyses were performed
separately on each of the four simulated populations independently to determine p-values. The
genome of each population was divided into 20-cM bin regions, and each bin was rank-ordered
based on the most significant linkage p-value for that population in that region. The bin ranks were
then averaged across all four studies to determine the most significant 20-cM regions over all
studies. Statistical significance of the averaged bin ranks was determined from a normal distribution
of randomly assigned rank averages. To narrow the region of interest for fine-mapping, the meta-
analysis was repeated two additional times, with each of the 20-cM bins offset by 7 cM and 13 cM,
respectively, creating regions of overlap with the original method. The 6–7 cM shared regions,
where the highest averaged 20-cM bins from each of the three offsets overlap, designated the
minimum region of maximum significance (MRMS). Application of the GSMA-MRMS method
revealed genome wide significance (p-values refer to the average rank assigned to the bin) at
regions including or adjacent to all of the simulated disease loci: chromosome 1 (p < 0.0001 for
160–167 cM, including D1), chromosome 3 (p-value < 0.0000001 for 287–294 cM, including D2),
chromosome 5 (p-value < 0.001 for 0–7 cM, including D3), and chromosome 9 (p-value < 0.05 for
7–14 cM, the region adjacent to D4). This GSMA analysis approach demonstrates the power of
linkage meta-analysis to detect multiple genes simultaneously for a complex disorder. The MRMS
method enhances this powerful tool to focus on more localized regions of linkage.
Background
After a genome scan, fine-mapping of the most promising
regions proceeds. Identification of the regions must be as
accurate as possible to minimize time and expense. In
complex diseases, there are often many research groups
working independently but cooperatively. A meta-analy-
sis of the genome scans from diverse research groups can
reveal the appropriate areas for fine-mapping. We pro-
posed to use the results from the individual genome scans
of the Genetic Analysis Workshop simulated populations
in a meta-analysis to assess the optimal chromosomal
region(s) to target for second stage fine-mapping. The
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genome scan meta-analysis (GSMA) [1,2] method is a
nonparametric rank ordering method that can combine
genome-scan methods across studies with different mark-
ers, and/or different statistical tests, and is robust to study
design and ascertainment differences. In simulation stud-
ies, the GSMA detected linkage with power comparable to
or greater than that obtained by performing a combined
linkage analysis of all the data [2]. An extension of the
GSMA method to determine the minimum regions of
maximum significance (MRMS) is used for revealing areas
for fine-mapping in complex diseases [3].
Methods
GSMA method
Linkage between traits and markers was assessed via non-
parametric multipoint linkage methods. For the multigen-
erational New York families, we used the descent graph
approach, utilizing computer program SIMWALK V2.89
[4], and MEGA2 V2.5.R4 utility program [5,6]. For the
nuclear families of the other 3 populations, we used MER-
LIN 0.10.1 [7]. Family data from all populations from rep-
licate 1 was used and the affection trait investigated was
the overall affection status of Kofendrerd Personality Dis-
order.
For the GSMA procedure, the genome was divided into
20-cM regions, with bin width selected such that there
were at least 2 bins on each chromosome and at least one
marker in each bin. For each of the 4 scans, bins were
assigned a rank (R, with values 1–144) according to the
most significant p-value of any markers within that bin.
Any ties were assigned equal ranks on the basis of the
mean of the sequential ranks for those bins. Higher values
of R represented the most significant p-values.
For each bin, the ranks were summed and averaged over
all four populations. Each population carried the same
weight.
A weighting scheme was considered because of the differ-
ing sample size of the populations and differing numbers
of affecteds in each family due to the ascertainment crite-
ria. The weighting scheme factor [2] depended on the
square root of the number of affecteds genotyped in each
study (N) divided by the mean of affecteds genotyped for
all 4 studies   The weights calculated were
close to 1.0, between 0.95 and 1.03, and therefore weight-
ing was not considered necessary.
Because no weighting scheme was used, statistical signifi-
cance of the average rank was determined by the normally
distributed probability function derived by assuming that
each of the independent possible average ranks were ran-
domly assigned [1].
Extension of GSMA to find MRMS
To narrow the regions of possible findings, we utilized an
extension of the GSMA procedure. We repeated the GSMA
procedure twice, assigning different bins to the map:
shortening the length of the first bin to 7 cM, then to 13
cM, but kept all subsequent bins to a length of 20 cM.
Thus we were able to determine the 6- to 7-cM region
overlap that was the minimum region of maximum signif-
icance (MRMS) [3]. Given that the scans averaged 7.5 cM
between markers, the 6 to 7 cM was the limit of resolution
for this meta-analysis.
Analysis proceeded without knowledge of the simulated
disease loci.
Results
Multipoint results in the four populations (Figure 1) indi-
cated 19 markers on 4 chromosomes with raw p-values
less than 0.001. Many more markers had raw p-values <
0.05. There were 7 markers on 4 chromosomes that met
the Bonferroni adjusted significance requirement, yet 6 of
these markers were significant in only one population
(D01S0022, D010023, D01S0024 in Danacaa and
D05S0172, D09S0347, D09S0348 in Karangar) and 1
marker (D03S0127) was significant in 2 populations
(Aipotu and Karangar).
The bin-shifting procedure and the MRMS method (Figure
2) identified 4 regions with genome-wide significance for
second stage fine-mapping: chromosome 1: 173 to 180,
() : N N
N Raw nonparametric linkage multipoint results Figure 1
Raw nonparametric linkage multipoint results. The 
red dashed line represents the 0.05 genome-wide significance 
level adjusted for multiple tests (Bonferroni adjustment). The 
other blue line indicates the unadjusted p-value of 0.001.
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chromosome 3: 313 cM to the end, chromosome 5: 0 to 7
cM, and chromosome 9: 7–13 cM. Regions adjacent to the
left of these 4 regions arguably could also be included in
fine-mapping, money and resources permitting. There-
fore, our proposed approach to combine data across
diverse populations (GSMA plus MRMS) correctly identi-
fied the simulated disease regions on chromosome 1, 3, 5
and the adjacent region on chromosome 9.
Discussion
The GSMA-MRMS procedure correctly identified the 3 dis-
ease regions on chromosomes 1, 3, and 5. The fourth dis-
ease region on chromosome 9 revealed by GSMA-MRMS
was directly adjacent to the simulated disease region. We
believe that the GSMA-MRMS method is superior to other
methods that might be used to identify localized regions
of linkage. Without the shifting of the bins (MRMS
method), the GSMA alone would have indicated a 20-cM
region on each of the chromosomes 1,3, 5, and 9, effec-
tively tripling the cost and time of the fine-mapping pro-
cedure. Using just the Bonferroni-corrected p-values from
the multipoint analysis, 3 regions varying from 14 to 33
cM would have been considered for fine-mapping on
chromosomes 1, 3, and 5. Using p-values < 0.001 from the
multipoint analysis, even larger regions varying from 24
to 44 cM would have been considered for fine-mapping
on chromosomes 1, 3, and 5. The GSMA-MRMS enhanced
method, in comparison to the alternative methods pre-
sented above, would be the most cost effective method for
identifying regions for second stage fine-mapping.
Graphic representation of the minimum regions of maximum significance (MRMS) for those chromosomes with GSMA-MRMS  values < 0.01 Figure 2
Graphic representation of the minimum regions of maximum significance (MRMS) for those chromosomes 
with GSMA-MRMS values < 0.01. The dashed vertical lines indicate the 6–7 cM MRMS region for chromosomes 1, 3, 5, and 
9 and therefore the regions targeted for SNP packet purchasing for fine-mapping.
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Conclusion
The GSMA method alone identified 20-cM regions while
the GSMA method followed by the MRMS narrowed the
regions to consider, leading to more efficient use of time,
resources and funds for follow-up fine-mapping studies.
With many investigators focusing on complex diseases
with sometimes conflicting findings from study to study,
and with the necessity to combine data across studies with
potentially different study designs, the GSMA-MRMS
methodology would expedite the discovery of a complex
disease's genetic basis.
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